← Open Payments lookup

TARA ELIZONDO: Open Payments

NPI 1760188502 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$475 in 26 payments from 10 companies in 2025. Trend: 2023 $1,003 · 2024 $554 · 2025 $475

Food & beverage: $475
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$105
Teva Pharmaceuticals USA, Inc.4$70
ABBVIE INC.4$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
E.R. Squibb & Sons, L.L.C.3$58
Janssen Pharmaceuticals, Inc2$35
Lundbeck LLC2$29
Alkermes, Inc.1$19
Axsome Therapeutics, Inc.1$16
Vanda Pharmaceuticals Inc.1$14

Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, AUSTEDO XR, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.